I was trying to help newbies on another forum and posted

New Post Public Reply Private Reply Replies (1) Message Board
petemantx
1,027
I was trying to help newbies on another forum and posted the below but it was deleted as being off-topic. Well done, SS, you A-hole.

For new people checking out IPIX, it has a lot to offer for both traders and investors.

Traders have made a lot of money due to the constant churning in the share price. Forces seem to want to keep the stock price contained but within a range so that money can be made almost daily as the price rises and settles back down at a fast clip. I am not a trader, don't know much about it, but over the years they have been the BIG winners to date.

As for investors, things have been rough for years due to financial concerns (nothing new when talking about a startup biotech with no products yet and drugs taking 10+ years and about $1B to see thru clinical trials) but events have started to move at a dazzling pace in the last 6 months or so and IPIX seems on the verge of finally capitalizing on its megastar drug, Brilacidin. Brilacidin is a synthetic drug, a defensin mimetic, formulated using tens of thousands of hours on super computers so its benefits are many and its drawbacks very small, if even existent.

Brilacidin is now on a pace to possibly cure all, or at least many, of the most severe lower GI tract problems to include Colitis and Crohn's Disease thru the delivery system of a pill. It is on the verge of going to a PhaseIII trial for Oral Mucositis, has already succeeded in a PhaseII antibiotic trial (ABSSSI), and is currently a leading hope to be a treatment or cure for CV19. It has had tests in governmental bio labs that established that it kills the corona virus, works on human kidney tissue in killing CV, and is nearly finished in testing on how it works regarding human lung tissue. Expectations are quite high, extremely high, for this important lung tissue test due to its past trial history. Then it will be ready for use in human CV trials and Brilacidin should become a worldwide household name. The current testing is expected to result in a lot of money (most think in the 10s of millions) granted to IPIX for furher investigation across many fields. Example: The lung testing, when shown successful, should then lead medical authorities to allow Brilacidin to be tested against COPD and Asthma. Its ability to handle CV should also make it a prime candidate as an adjuvant for ALL other virus vaccines, including the flu. To date, it has NEVER met a bacteria in trials it couldn't kill - to include black plague, about 9 different strains of anthrax, etc.

IPIX also has another drug, Kevetrin, that has shown AMAZING results to date in use as a cancer treatment or adjuvant to ALL current cancer treatments. It is the only current drug that has shown it can activate the p53 gene, named the Guardian Angel gene, as it causes the production of the body's natural defensive agents. It needs to be formulated into a pill and currently the pill is about 1/2 way thru tox tests. It is on hold due to lack of funds to proceed further at the current time. But with the expected government grants on the extremely near horizon (most expect grants within a matter of weeks if lung tissue test results are quite good) the Kevetrin pill will be able to be finished and then be put into quite a battery of trials as a stand alone and, more importantly, as an aid to all other current toxic cancer treatments.

The final piece of the puzzle for BOTH Brilacidin and Kevetrin is that besides showing trial results to date of being extremely effective (efficacious), they are also blessed with safety profiles that are so good, having next to NO negative side effects, that they are marvels in the world of medicine today.

Most the boo-hooing you hear on this board is by the traders as they live and die by the daily share price. The true investors you don't hear much from as the trial results speak for themselves. This investment could be the one of a lifetime if things progress as they have been progressing. But then nothing is ever guaranteed so being such a high risk stock be sure that you don't invest what you can't afford to lose.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top Tax Expert Holly Paz Joins alliant's Elite Team

Updated Category News Views 6

Big Leagues in Tax: Holly Paz Joins alliant Tax is one of those fields that's not for the faint of heart. It's complex, ever-changing, and can make or break businesses. Enter Holly Paz, once at the helm of the IRS's Large Business & International Division, now bringing her vast experience to alliant. Paz is a bona fide heavyweight in tax administration, and her arrival at...

Continue Reading
ASUR Scales Up: Acquires 20 Latin American Airports

Updated Category News Views 2

A Bold Move in a Competitive Market I'll tell you, it's not every day you see a company like Grupo Aeroportuario del Sureste, S.A.B. de C.V. (NYSE: ASR) make a nearly billion-dollar move. This ain't some pocket change acquisition. We're talking about sealing the deal for Motiva's interests—R$5.1 billion (or nearly $992 million USD) to grab 20 airports in Brazil,...

Continue Reading
Leopard Imaging's DragonFire Aims at Industrial Heat Tracking

Updated Category News Views 0

DragonFire: A New Player in Industrial Thermal Imaging Leopard Imaging is strutting onto the thermal imaging stage with a fresh piece of tech—DragonFire. Now, this ain't just another gadget in a long line of gizmos. Unlike your run-of-the-mill cameras, this one packs a punch with its high-resolution uncooled infrared capability. Imagine the kind of precision you can...

Continue Reading
Fibocom's RU311: Navigating 5G's Mid-Tier Maze

Updated Category News Views 4

Cracking Open the RU311 Phenomenon Technology must evolve with purpose. This time around, Fibocom's RU311 module series steps up to the plate, delivering a tailored solution in the 5G landscape for the mid-tier IoT devices that need more than just speed. Beyond Raw Bandwidth: What Really Matters Plenty of folks out there still chase the elusive thrill of higher speeds as...

Continue Reading
MEGA SHOW 2026: Asia's Premier Sourcing Powerhouse

Updated Category News Views 3

MEGA SHOW 2026: Where Asian Sourcing Dreams Come True Anything worthwhile demands a veteran’s eye and a seasoned gut feeling. Swapping tales of the pavement or sifting through digital noise has me biting into MEGA SHOW Hong Kong 2026, an annual heavyweight event that stands as a prime stop on the autumn calendar for industry movers and shakers. We've circled back to the...

Continue Reading
Student Mobility and Education: A Vital Intersection

Updated Category News Views 2

Ritu Narayan’s Book Sparks a Vital Conversation They say never judge a book by its cover, but Ritu Narayan’s newly crowned bestseller, The Most Important Commute, begs us to look beyond the page: it's the saga of a bus ride, as mundane as rain until you peel back the layers of what it means for education today. Could something as seemingly simple as a school bus ride...

Continue Reading
Edgewell Prepares for Key Discussion at Barclays Conference

Updated Category News Views 0

Upcoming Fireside Chat: Edgewell's Moment of Candor Alright, folks, Edgewell Personal Care Company is about to sit in a hot seat, at the Barclays 19th Annual Global Consumer Conference. You know the deal, it’s where big shots like Rod Little, the President and CEO, and Fran Weissman, the CFO, spill the beans about where the company might be headed next. Hold on to your...

Continue Reading
Skanska's $57M Deal to Transform Del Mar Traffic

Updated Category News Views 5

A Roadway Overhaul in Del Mar A cool $57 million. That’s the ticket Skanska bought to scoop up the El Camino Real project in Del Mar, California. Think of it as a road facelift, a necessary one—it includes bulking up the corridor to four lanes and swapping in a spanking new San Dieguito River Bridge, taking the place of an old rascal that's been around for 84 years....

Continue Reading
OCI Energy and Arava Power Ignite SunRoper Solar Project

Updated Category News Views 6

Bridging Houston's Energy Gap with New Solar Power There's a new player in town aiming to meet the growing electricity demand in the Houston area. On September 1, 2026, OCI Energy and Arava Power, along with their project partners, broke ground on the SunRoper Solar project in Wharton County, Texas. This isn't just any solar venture; it's a hefty 347 MWdc facility that's...

Continue Reading
York Space Systems Faces Class Action After IPO Issues

Updated Category News Views 1

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Announced for Symbotic Inc. Shareholders

Updated Category News Views 146

Investigation Announced for Symbotic Inc. Shareholders Rosen Law Firm, well-known for advocating investor rights, is currently conducting an investigation regarding potential securities claims for shareholders of Symbotic Inc. (NASDAQ: SYM). This investigation arises from allegations suggesting that Symbotic may have provided misleading business information to its...

Continue Reading
Legal Action Erupts as C3.ai Faces Investor Claims Over Misleading Info

Updated Category News Views 200

C3.ai Faces Legal Challenges Amid Investor Concerns In a significant development, investors are stepping forward with allegations against C3.ai, a leader in enterprise AI software. The claims center on accusations that the company misrepresented its financial health and growth potential, potentially misleading its stakeholders. This lawsuit, filed in a U.S. District...

Continue Reading
Exploring Nanning: A City Where Cultures Meet and Flourish

Updated Category News Views 208

Nanning: A City of Cultural Diversity Nanning, a Chinese city brimming with vitality and historical legacy, offers a wonderful blend of cultural charm and contemporary allure. A multinational cohort of young explorers from Gen Z — hailing from various nations—set out to discover the multifaceted romance of Nanning from various vantage points. Their journey took them...

Continue Reading
Pye-Barker Fire & Safety Expands Services Through Acquisition

Updated Category News Views 262

Pye-Barker Fire & Safety Expands Services Through Acquisition Pye-Barker Fire & Safety has successfully acquired General Sprinkler Corporation, marking a significant step in their mission to provide comprehensive fire protection services. This acquisition will enhance Pye-Barker's capabilities in regions they have served, extending their footprint in the Midwest. About...

Continue Reading
InHouse by MariMed Initiates Housing Support for Veterans

Updated Category News Views 71

InHouse by MariMed Launches a New Initiative for Veterans NORWOOD, Mass. — In an inspiring move to support those who have served their country, MariMed introduces its philanthropic initiative, Help on the Homefront. This program aims to address the significant housing challenges faced by veterans across various regions. MariMed’s InHouse line, known for its premium...

Continue Reading